Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
CR Bard
D/E
=
Total Debt
Total Equity
=
0.74 times
High Debt to Equity ratio typically indicates that a firm has been barrowing aggressive to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging barrowing against the capital invested by the owners.
According to company disclosure CR Bard Inc has Debt to Equity of 0.74 times. This is 23.33% higher than that of Healthcare sector, and 117.65% higher than that of Medical Instruments and Supplies industry, The Debt to Equity for all stocks is 85.0% lower than the firm.
Filter other Stocks by Debt to Equity
Select Debt to Equity Range
Current Range
Indicate Industry
Click to run this filter
Filter Other Equities
Debt to Equity Comparison
CR Bard is rated fourth in debt to equity category among related companies.
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
NYSE CR Bard Inc
-0.06% 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
